PATIENT INFORMATION LEAFLET

Similar documents
PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET. Active substances: Each 5 ml syrup (1 spoon) contains 2.5 mg desloratadine.

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER Clotrimazole Cream 1%

PATIENT INFORMATION LEAFLET

Patient Leaflet : Information for the user Locoid Cream 0.1% w/w Hydrocortisone butyrate

1g cream or ointment contains 1 mg methylprednisolone aceponate.

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the patient UNITED KINGDOM Feldene 5mg/g Gel piroxicam

PATIENT INFORMATION LEAFLET

Patient Information Leaflet

PATIENT INFORMATION LEAFLET TREGS

Package leaflet: Information for the user. Fluticrem 0.05% cream Fluticasone propionate

Package leaflet: Information for the user. Zidoval 7.5 mg/g Vaginal Gel Metronidazole

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

CONSUMER MEDICINE INFORMATION CLOTRIZONE CREAM

Package leaflet: Information for the patient. Xemacort 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Lidokain Isdin 40 mg/g cream. Lidocaine

PATIENT INFORMATION LEAFLET

TAFEN NASAL 50mcg nasal spray, suspension

1.3.1 PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient

Hydrocortisyl Skin Cream 1% Hydrocortisone

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:

FASTUM 2.5% gel PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT FASTUM GEL IS AND WHAT IT IS USED FOR

PATIENT INFORMATION LEAFLET TEXAMER

PACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Package leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride

Package leaflet: Information for the patient. Mometasone furoate 0.1%w/w Ointment (mometasone furoate)

Core Safety Profile. Pharmaceutical form(s)/strength: solution 1%, spray 1%, cream 1%, gel 1% SK/H/PSUR/0005/001 Date of FAR:

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

2. What you need to know before you are given Konakion MM. Package Leaflet: Information for the patient

Consumer Medicine Information PIMAFUCORT

PATIENT INFORMATION LEAFLET. Excipients: Sorbitol 70% (E420), glycerol, hydroxyethyl cellulose, mint flavor, purified water.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cinfalair 4 mg chewable tablets

Package leaflet: Information for the user. Zoviduo 50 mg/g and 10 mg/g cream. Aciclovir and Hydrocortisone

PATIENT INFORMATION LEAFLET. Urea 10% w/w Cream

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

1. WHAT IS CANESTEN HC CREAM AND WHAT IS IT USED FOR?

Package leaflet: Information for the user. Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride

Consumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules.

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

LYSOBACT COMPLETE SPRAY ( ) mg / ml Oromucosal spray, solution

PATIENT INFORMATION LEAFLET. Naseptin Nasal Cream chlorhexidine dihydrochloride and neomycin sulfate

Package leaflet: Information for the user

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

Package leaflet: Information for users. Imodium 2 mg orodispersible tablets Loperamide hydrochloride

1. What Solpadol is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate

PATIENT INFORMATION LEAFLET EFFERFLU C IMMUNE BOOSTER. EFFERFLU C IMMUNE BOOSTER has not been evaluated by the Medicines Control

Package leaflet: Information for the patient. Migräne-Kranit 500 mg Tablets. Active substance: phenazone

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

RESOLVE PLUS 1.0 Hydrocortisone, miconazole nitrate

PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide. 1. What Pulmicort Turbohaler is and what it is used for

If you have any questions about how Letrozole Tablets works or why this medicine has been prescribed for you, ask your doctor.

PHOLCODINE. Please follow the instructions on the packaging of the medicine you purchased and in this leaflet before you start using pholcodine.

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

Proctosedyl Ointment Hydrocortisone/Cinchocaine hydrochloride/framycetin sulphate/aesculin

Dorzolamide 20 mg/ml Eye Drops, Solution

Package leaflet: Information for the patient. Bromhexin Krewel Meuselbach Drops 12 mg/ml. Bromhexine hydrochloride

ILUVIEN 190 micrograms intravitreal implant in applicator (fluocinolone acetonide)

Package leaflet: Information for the user. Qutenza 179 mg cutaneous patch capsaicin

Zatamil Mometasone furoate 0.1% w/w

Do not use Allergo-COMOD eye drops - if you are hypersensitive against sodium cromoglicate (Ph. Eur.) or one of the other ingredients.

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

Unofficial translation of the German package leaflet. Package leaflet: Information for the user

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Cutivate 0.05% w/w Cream fluticasone propionate

Package leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets

Read this entire leaflet carefully before you start taking DYNA BEZAFIBRATE. If you have further questions, please ask your doctor or your pharmacist.

POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin

PACKAGE LEAFLET: INFORMATION FOR THE USER

Dalacin C 150 mg Hard Capsules Clindamycin (as clindamycin hydrochloride)

Zinnat can also be used: to treat Lyme disease (an infection spread by parasites called ticks).

ANBESOL Liquid Lidocaine Hydrochloride, Chlorocresol and Cetylpyridinium Chloride

PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone

PACKAGE LEAFLET: INFORMATION FOR THE USER. Flutarzole 0,05% w/w cream, Fluticasone propionate

TRIPROLIDINE. Please read this leaflet and the packaging of the medicine you purchased, carefully before you start using triprolidine.

PATIENT INFORMATION LEAFLET AMLOC RANGE

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Rectogesic 4 mg/g Rectal Ointment Glyceryl trinitrate

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)

Package leaflet: Information for the patient. Trasylol 10,000 KIU/ml solution for injection or infusion. Aprotinin

Transcription:

HAMAZINC 5.35% + 18% cream For external use only. PATIENT INFORMATION LEAFLET Active substances: Each gram of cream contains; 53.5 mg hamamelis virginiana distillate and 180.00 mg zinc oxide. Excipients: Methyl paraben (E218), ethyl paraben (E214), propyl paraben (E216), cetomagrogol 1000, propylene glycol, cetostearyl alcohol, liquid paraffin, white paraffin and deionized water. Read this PATIENT INFORMATION LEAFLET carefully before you start taking this medicine, because it contains important information for you. This medicine is available without prescription for you to treat minor disorders without a doctor s help, with the recommendation of your pharmacist. However, you still need to use HAMAZINC carefully to get the best results from it. Keep this leaflet. You may need to read it again. If you have any further questions, please ask your doctor or pharmacist. This medicine has been prescribed for you only, do not pass it on to others. When you go to a doctor or hospital while using this medicine, tell your doctor that you are receiving this medicine. Follow strictly what has written on this leaflet. Do not use higher or lower doses than the dose which was recommended for you. What is in this leaflet: 1. What HAMAZINC is and what is it used for? 2. Before you use HAMAZINC 3. How to use HAMAZINC? 4. Possible side effects 5. How to store HAMAZINC? 1. What HAMAZINC is and what is it used for? HAMAZINC is a white appearance cream used externally containing hamamelis virginiana distillate and zinc oxide which is marketed in 30 g, 60 g and 90 g aluminum tubes. The Hamamelis virginiana aqueous extract present in HAMAZINC composition has tissue constrictor (astringent), local stops bleeding (hemostatic) and reduces inflammation (anti-inflammatory) activities. Following skin injuries, the tissue constrictor effect provides tissue thickening by causing coagulation of skin proteins at the injury site. Sayfa 1 / 5

The local hemostatic effect reduces bleeding time and accelerates clotting at the injury site following a skin injury. It relieves signs and symptoms of inflammation of the skin with its anti-inflammatory activity. Zinc oxide reduces inflammation and tissue death in damaged and injured skin and accelerates wound healing in the injury site by increasing skin cell growth. HAMAZINC; - Diaper rash in babies and young children - Maintenance treatment for diaper rash aggravating due to fungal infections or bacterial infections - First and second degree burns/sunburn - Superficial skin lesions (injuries) including scratches and cuts - Care and prevention of cracked nipples in nursing mothers - Care and protection of dry, cracked, split skin (including skin of the elderly and treatment of diabetic foot) - This product can be used as an adjunct to treatment of skin disease which is manifested with tissue disorders such as redness, itching, exudate, scabbing caused by various reasons as a result of treatment with other medicines, rapidly growing and exudating wound like skin damage due to rubbing or microbes such as fungus on skin and especially leg wounds and wounds that occurs in patients lying down for a long time. 2. Before you use HAMAZINC DO NOT use HAMAZINC Do not use if you are allergic to any of the ingredients of HAMAZINC. TAKE SPECIAL CARE with HAMAZINC in the following conditions: Contact of HAMAZINC with eyes should be avoided. In case of contact with eyes, eyes should be washed with plenty of water. If current complaints persist or worsen despite using HAMAZINC, a doctor should be consulted. Please consult your doctor, even if these statements were applicable to you at any time in the past. Using HAMAZINC with food and drink: There is no special indication regarding using HAMAZINC with food and drink. Pregnancy Ask your doctor or pharmacist for advice before taking the medicine. For Hamamelis virginiana, no clinical data on exposed pregnancies are available. For zinc oxide, no clinical data on exposed pregnancies are available. Animal studies are also unavailable. Sayfa 2 / 5

Caution should be used if HAMAZINC is to be used during pregnancy. If you notice that you are pregnant during treatment, please consult your doctor immediately. Breast-feeding Ask your doctor or pharmacist for advice before taking the medicine. It is not known whether Hamamelis virginiana passes into human milk. Excretion of Hamamelis virginiana into milk in animals was also not investigated. It is not known whether zinc oxide passes into human milk. Consult your doctor about using HAMAZINC during lactation. Driving and using machines: There is no known effect on driving and using machines. Important information about some of the excipients of HAMAZINC Local skin reactions (for example, contact dermatitis with irritant or allergic ingredients directly associated with skin inflammation) and skin irritation may rarely occur due to propylene glycol and cetostearyl alcohol contents. The methylparaben (E218), ethylparaben (E214), propylparaben (E216) contents of HAMAZINC may cause allergic (potentially delayed) reactions. Using with other medicines No interaction of HAMAZINC with other medicinal products via the topical route was reported. Please tell your doctor or pharmacist if you are taking or have recently taken any other prescription or nonprescription medicine. 3. How to use HAMAZINC? Instructions for appropriate method and dose/frequency of administration: Apply HAMAZINC few times a day to the lesion area. There is no time limitation to using HAMAZINC. Route and method of administration: Apply HAMAZINC to the lesion area as a thin layer. Lesion area can be covered with gauze bandage following application, if necessary. For nipple care of nursing mothers, HAMAZINC is applied to the nipples after each breastfeeding. Various age groups: Use in children: Use in elderly: Special Populations Kidney/Liver failure: If you have the impression that the effect of HAMAZINC is too strong or too weak, talk to your doctor or pharmacist. Sayfa 3 / 5

If you have used more HAMAZINC than you should: If you may have taken more HAMAZINC than you should, talk to a doctor or pharmacist. If you forget to use HAMAZINC: Do not use double dose to make up for the dose you forgot. If you stop using HAMAZINC: No effect is expected. 4. Possible side effects Like all medicines, side effects can occur in people sensitive to the contents of HAMAZINC. If any of the following occur stop using HAMAZINC and IMMEDIATELY inform your doctor or go to the nearest emergency department. Swelling of hands, feet, ankles, face, lips or specific swelling of mouth cavity and throat causing difficulty in breathing These are very serious side effects. If you have any of them, this means you have serious allergy for HAMAZINC. You may need emergency medical care or hospitalization. All of these very serious side effects occur very rarely. Side effects are classified by the following categories: Very common (occurring in at least 1 of 10 patients); Common (occurring in less than 1 of 10 but in more than 1 of 100 patients); Uncommon (occurring in less than 1 of 100 but more than 1 in 1.000 patients); Rare (occurring in less than 1 in 10.000 patients); Very rare (occurring in less than 1 of 10.000 patients); Unknown (Cannot be estimated from the available data), Uncommon (occurring in less than 1 of 100 but more than 1 in 1.000 patients) Skin rashes that spread uniformly in the skin, suddenly spontaneously, and disappear without recurring skin changes, symptomatic skin rash (exanthema) Skin irritation, itching, burning and stinging sensation Skin redness (erythema) Dry skin Unknown (cannot be estimated with the available data) Allergic reaction Skin irritation (eczema), which is caused by irritant or allergenic substances, direct skin contact inflammation (contact dermatitis), tissue disorders such as redness, itching, watering, incrustation Hives (urticarial), allergic skin rash Allergic skin disorder (angioneurotic edema) caused by large, painless swelling that is restricted to a certain area under the skin If you notice any side effects not mentioned in this leaflet inform your doctor or pharmacist. Sayfa 4 / 5

5. How to store HAMAZINC Keep in the original package and out of the reach and sight of children. Store at room temperature below 25 Use in accordance with the expiry date. Use HAMAZINC before the expiry date indicated on the tube or package. Do not use HAMAZINC if you notice any damage to the product and/or package. Marketing authorization holder: Berko İlaç ve Kimya Sanayi A.Ş. Yenişehir Mah. Özgür Sok. No: 16-18 Ataşehir/İstanbul-Turkey +90 216 456 65 70 (Pbx) +90 216 456 65 79 (Fax) info@berko.com.tr Manufacturer: Berko İlaç ve Kimya Sanayi A.Ş. Adil Mah. Yörükler Sok. No: 2 Sultanbeyli/İstanbul-Turkey +90 216 592 33 00 (Pbx) +90 216 592 00 62 (Fax) This patient information leaflet was last approved on 28/05/2018. Sayfa 5 / 5